Suppr超能文献

用热熔挤出法与各种节省材料的技术相结合制备三氯苯达唑无定形固体分散体。

Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions.

机构信息

College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA.

College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA; Continuus Pharmaceuticals Inc, Woburn, MA, USA.

出版信息

Int J Pharm. 2023 Jun 10;640:122989. doi: 10.1016/j.ijpharm.2023.122989. Epub 2023 Apr 28.

Abstract

Amorphous solid dispersions (ASD) are one of the most adopted technologies for improving the solubility of novel molecules. Formulation of ASDs using solvent free methods such as hot melt extrusion (HME) has been in the spotlight off-lately. However, early-stage formulation development is tricky and a difficult bridge to pass due to limited drug availability. Material-sparing techniques (theoretical & practical) have been used for selecting suitable polymeric carriers for formulating ASDs. However, these techniques have limitations in predicting the effect of process parameters. The objective of this study is to use both theoretical and practical material-sparing techniques to optimize a polymer for the developing Triclabendazole (TBZ) ASDs. Initial screening by theoretical approaches suggested that TBZ is highly miscible with Kollidon®VA64 (VA64) and poorly miscible with Parteck®MXP (PVA). However, results from ASDs prepared using SCFe were opposite to these predictions. ASDs prepared using either technique and both VA64 and PVA showed >200x increase in solubility. Each formulation released >85% of drug in less than 15 mins. Although the thermodynamic phase diagram suggested that VA64 was the ideal polymer for TBZ-ASDs, it has certain limitations in factoring the different elements during melt-processing and hence, practical approaches like SCFe could help in predicting the drug-polymer miscibility for HME processing.

摘要

无定形固体分散体(ASD)是提高新分子溶解度最常用的技术之一。最近,无溶剂方法(热熔挤出(HME))制备 ASD 受到了关注。然而,由于药物供应有限,早期制剂开发具有挑战性,是一个难以跨越的障碍。已经使用节省材料的技术(理论和实践)来选择合适的聚合物载体来制备 ASD。然而,这些技术在预测工艺参数的影响方面存在局限性。本研究的目的是使用理论和实践的节省材料技术来优化用于开发三氯苯达唑(TBZ)ASD 的聚合物。通过理论方法进行的初步筛选表明,TBZ 与 Kollidon®VA64(VA64)高度混溶,与 Partek®MXP(PVA)则较差混溶。然而,使用 SCFe 制备的 ASD 的结果与这些预测相反。使用这两种技术以及 VA64 和 PVA 制备的 ASD 均显示溶解度增加超过 200 倍。每种制剂在不到 15 分钟内释放超过 85%的药物。尽管热力学相图表明 VA64 是 TBZ-ASD 的理想聚合物,但在熔融加工过程中考虑不同因素时存在某些局限性,因此,类似 SCFe 的实际方法有助于预测 HME 加工过程中的药物-聚合物混溶性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验